Brief: Revelation Biosciences Selects Avance Clinical As Cro For Phase 2/3 Titan Study

Revelation Biosciences

19/08/2026 14:01

Revelation Biosciences Inc  REVB.O :
    * REVELATION BIOSCIENCES SELECTS AVANCE CLINICAL AS CRO FOR
PHASE 2/3 TITAN STUDY
    * REVELATION BIOSCIENCES - PHASE 2/3 TITAN STUDY EXPECTED TO
BEGIN LATER THIS YEAR

Source text:  ID:nBw53q34La 
Further company coverage:  REVB.O